Aptargroup (ATR) Long-Term Investments (2009 - 2026)
Aptargroup's (ATR) quarterly Long-Term Investments came in at $130.8 million in Q1 2026, down 11.46% year-on-year from $147.7 million in Q1 2025, and little changed on a QoQ basis from $131.0 million in Q4 2025.
Aptargroup (ATR) Long-Term Investments (2009 - 2026) Analysis & Trends
Aptargroup (ATR) has 18 years of Long-Term Investments data on file, last reported at $130.8 million in Q1 2026.
- On a quarterly basis, Long-Term Investments fell 11.46% year-over-year to $130.8 million in Q1 2026; TTM through Mar 2026 was $130.8 million, a 11.46% decrease from a year earlier, with the FY2025 full-year figure at $131.0 million, down 10.42% from the prior year.
- Long-Term Investments for Q1 2026 stood at $130.8 million, roughly flat from $131.0 million in the prior quarter.
- Over the last five years, Long-Term Investments for ATR reached as high as $154.1 million in Q2 2025 and fell as low as $48.0 million in Q3 2023.
- Historically, Long-Term Investments has averaged $82.8 million across 5 years, with a median of $53.8 million in 2022.
- Across the five-year window, Long-Term Investments retreated 17.43% in 2022 and jumped 217.56% in 2025, its largest moves.
- Year by year, Long-Term Investments stood at $52.3 million in 2022, then declined by 5.94% to $49.2 million in 2023, then jumped by 197.28% to $146.3 million in 2024, then dropped by 10.42% to $131.0 million in 2025, then dropped by 0.21% to $130.8 million in 2026.
- Per Business Quant data, the three most recent Long-Term Investments figures were $130.8 million in Q1 2026, $131.0 million in Q4 2025, and $130.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 800.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 3.41 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 207.70 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | - |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | - |
| 10 | Aptargroup | 9.43 Bn | 9.23 Bn | 351.91 Mn | 130.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 130.76 Mn |
| Dec 31, 2025 | 131.03 Mn |
| Sep 30, 2025 | 130.35 Mn |
| Jun 30, 2025 | 154.10 Mn |
| Mar 31, 2025 | 147.69 Mn |
| Dec 31, 2024 | 146.27 Mn |
| Sep 30, 2024 | 51.05 Mn |
| Jun 30, 2024 | 48.53 Mn |
| Mar 31, 2024 | 48.91 Mn |
| Dec 31, 2023 | 49.20 Mn |
| Sep 30, 2023 | 48.02 Mn |
| Jun 30, 2023 | 53.88 Mn |
| Mar 31, 2023 | 52.58 Mn |
| Dec 31, 2022 | 52.31 Mn |
| Sep 30, 2022 | 51.49 Mn |
| Jun 30, 2022 | 53.84 Mn |
| Mar 31, 2022 | 57.14 Mn |
| Dec 31, 2021 | 59.49 Mn |
| Sep 30, 2021 | 62.34 Mn |
| Jun 30, 2021 | 65.20 Mn |